Legal & General Group PLC Vertex Pharmaceuticals Inc Transaction History

Legal & General Group PLC

  • $357 Billion
  • Q1 2025

A detailed history of Legal & General Group PLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Legal & General Group PLC holds 1,894,169 shares of VRTX stock, worth $826 Million. This represents 0.26% of its overall portfolio holdings.

Number of Shares
1,894,169
Previous 1,884,153 0.53%
Holding current value
$826 Million
Previous $759 Million 21.03%
% of portfolio
0.26%
Previous 0.21%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 15, 2025
BUY
$402.49 - $513.76 $4.03 Million - $5.15 Million
10,016 Added 0.53%
1,894,169 $918 Million
Q4 2024

Feb 13, 2025
SELL
$396.64 - $516.74 $166 Million - $217 Million
-419,644 Reduced 18.22%
1,884,153 $759 Million
Q3 2024

Feb 28, 2025
BUY
$460.0 - $505.78 $9.73 Million - $10.7 Million
21,159 Added 1.12%
1,905,312 $886 Million
Q3 2024

Nov 14, 2024
SELL
$460.0 - $505.78 $54.7 Million - $60.1 Million
-118,880 Reduced 4.91%
2,303,797 $1.07 Billion
Q2 2024

Aug 14, 2024
BUY
$392.81 - $485.53 $11.4 Million - $14.1 Million
29,104 Added 1.22%
2,422,677 $1.14 Billion
Q1 2024

May 14, 2024
SELL
$407.69 - $446.08 $15.1 Million - $16.5 Million
-37,092 Reduced 1.53%
2,393,573 $1 Billion
Q4 2023

Feb 15, 2024
BUY
$343.0 - $410.68 $134 Million - $160 Million
390,307 Added 19.13%
2,430,665 $989 Million
Q3 2023

Nov 14, 2023
SELL
$338.18 - $362.46 $29.9 Million - $32.1 Million
-88,561 Reduced 4.16%
2,040,358 $710 Million
Q2 2023

Aug 14, 2023
BUY
$314.42 - $351.91 $13.4 Million - $15 Million
42,588 Added 2.04%
2,128,919 $749 Million
Q1 2023

May 15, 2023
BUY
$283.23 - $323.1 $15 Million - $17.1 Million
52,967 Added 2.6%
2,086,331 $657 Million
Q4 2022

Feb 14, 2023
SELL
$285.76 - $321.48 $29.9 Million - $33.7 Million
-104,734 Reduced 4.9%
2,033,364 $587 Million
Q3 2022

Nov 14, 2022
SELL
$273.83 - $305.53 $17.2 Million - $19.1 Million
-62,651 Reduced 2.85%
2,138,098 $619 Million
Q2 2022

Aug 22, 2022
BUY
$234.96 - $292.55 $33.7 Million - $42 Million
143,620 Added 6.98%
2,200,749 $620 Million
Q1 2022

May 16, 2022
BUY
$221.42 - $260.97 $35.1 Million - $41.4 Million
158,485 Added 8.35%
2,057,129 $537 Million
Q4 2021

Feb 14, 2022
SELL
$177.01 - $223.45 $30 Million - $37.9 Million
-169,690 Reduced 8.2%
1,898,644 $417 Million
Q3 2021

Nov 15, 2021
BUY
$181.39 - $202.99 $21.6 Million - $24.2 Million
119,277 Added 6.12%
2,068,334 $375 Million
Q2 2021

Aug 12, 2021
BUY
$187.49 - $221.1 $45.1 Million - $53.2 Million
240,660 Added 14.09%
1,949,057 $393 Million
Q1 2021

May 17, 2021
SELL
$207.02 - $241.31 $2.47 Million - $2.88 Million
-11,931 Reduced 0.69%
1,708,397 $367 Million
Q4 2020

Feb 12, 2021
BUY
$207.01 - $276.09 $7.13 Million - $9.5 Million
34,424 Added 2.04%
1,720,328 $407 Million
Q3 2020

Nov 13, 2020
BUY
$255.65 - $303.1 $12.1 Million - $14.3 Million
47,162 Added 2.88%
1,685,904 $459 Million
Q2 2020

Aug 14, 2020
BUY
$225.48 - $295.8 $12.2 Million - $16 Million
53,940 Added 3.4%
1,638,742 $476 Million
Q1 2020

May 14, 2020
BUY
$199.77 - $247.81 $13.3 Million - $16.5 Million
66,406 Added 4.37%
1,584,802 $377 Million
Q4 2019

Feb 13, 2020
BUY
$166.71 - $223.91 $9.25 Million - $12.4 Million
55,481 Added 3.79%
1,518,396 $332 Million
Q3 2019

Nov 13, 2019
BUY
$166.23 - $187.09 $548,060 - $616,835
3,297 Added 0.23%
1,462,915 $248 Million
Q2 2019

Aug 14, 2019
BUY
$164.61 - $190.37 $1.37 Million - $1.58 Million
8,308 Added 0.57%
1,459,618 $268 Million
Q1 2019

May 15, 2019
BUY
$163.73 - $194.7 $48.7 Million - $58 Million
297,731 Added 25.81%
1,451,310 $267 Million
Q4 2018

Feb 15, 2019
BUY
$151.91 - $192.21 $12 Million - $15.2 Million
79,216 Added 7.37%
1,153,579 $191 Million
Q3 2018

Nov 20, 2018
BUY
$167.73 - $192.74 $3.46 Million - $3.98 Million
20,630 Added 1.96%
1,074,363 $207 Million
Q2 2018

Aug 10, 2018
SELL
$145.72 - $169.96 $6.33 Million - $7.38 Million
-43,434 Reduced 3.96%
1,053,733 $179 Million
Q1 2018

May 17, 2018
SELL
$151.6 - $177.13 $8.17 Million - $9.55 Million
-53,915 Reduced 4.68%
1,097,167 $179 Million
Q4 2017

Feb 13, 2018
BUY
$137.28 - $155.55 $158 Million - $179 Million
1,151,082
1,151,082 $173 Million

Others Institutions Holding VRTX

# of Institutions
1,830
Shares Held
233M
Call Options Held
1.38M
Put Options Held
1.08M
View Full List

About VERTEX PHARMACEUTICALS INC

VRTX Quotes by TradingView
  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $112B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Legal & General Group PLC Portfolio

Follow Legal & General Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email